Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention
Yesehak Abraham/LinkedIn
Apr 29, 2026, 14:03

Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention

Yesehak Abraham, Social Media Manger at Sheromeda Gebya, Sales and Marketing Officer at Ze-el Pharmaceutical Import, shared a post on LinkedIn:

“Enoxaparin: The Quiet Hero in Blood Clot Prevention

Most people never think about blood clots… until they become a problem.

That’s where Enoxaparin steps in a small injection with a big clinical impact.

What it does :

It helps prevent dangerous clots by slowing down specific clotting factors (especially Factor Xa), keeping blood flow smooth and safe.

Where it’s commonly used:

  • Post – surgery patients
  • Bedridden or immobile patients
  • Acute coronary syndromes
  • DVT/PE prevention and treatment

Clinical reality:

Predictable. Effective. No routine monitoring in most cases.

But always respect renal function and bleeding risk.

‘Enoxaparin doesn’t dissolve clots… it just politely stops them from forming group chats in your bloodstream.’

Patient reminder:

  • Small bruises can be normal
  • Don’t massage injection sites
  • Report unusual bleeding immediately

Final thought:

Sometimes the most powerful treatments are not dramatic –  just precise, consistent, and quietly life – saving.”

Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention

Stay updated with Hemostasis Today.

Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine Yesehak Abraham
NewsFeed